Myelodysplastic disorders with hemizygous M-CSF receptor gene loss do not show point mutations of codon 969 within the remaining allele.

Myelodysplastic disorders with hemizygous M-CSF receptor gene loss do not show point mutations of codon 969 within the remaining allele.

Bibliographic Details
Main Authors:	Jaquet, K, Kreipe, H, Felgner, J, Boultwood, J, Parwaresch, MR
Format:	Journal article
Language:	English
Published:	1993

Similar Items

Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.
by: Boultwood, J, et al.
Published: (1991)

Loss of X-linked Protocadherin-19 differentially affects the behavior of heterozygous female and hemizygous male mice.
by: Hayashi, S, et al.
Published: (2017)

The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (2014)

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
by: Bernard, E, et al.
Published: (2020)

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
by: Pellagatti, A, et al.
Published: (2016)

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
by: Armstrong, R, et al.
Published: (2017)

Clonality in the myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (2001)

Effects Of Li-Agonist L-644,969 On Energy Metabolism In Broilers
by: Perpustakaan UGM, i-lib
Published: (1999)

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia.
by: Watkins, F, et al.
Published: (2004)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
by: Malcovati, L, et al.
Published: (2011)

Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations.
by: Thakker, R, et al.
Published: (1993)

Molecular pathogenesis of the myelodysplastic syndromes
by: Boultwood, J, et al.
Published: (1999)

Quantitative oxidation of nutrients in broiler treated with b-agonist l-644,969
by: Perpustakaan UGM, i-lib
Published: (2000)

Telomere length in myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (1995)

ISOLATION OF YACS FOR CSF-1R AND CSF-1 AND GENE LOCALIZATION USING FISH
by: Boultwood, J, et al.
Published: (1992)

Presence of allelic loss and PTEN mutations in malignant gliomas from Malay patients
by: Zainuddin, Norafiza, et al.
Published: (2004)

Clinical and biological implications of driver mutations in myelodysplastic syndromes.
by: Papaemmanuil, E, et al.
Published: (2013)

Myelodysplastic syndrome due to somatic GATA1 mutation.
by: Freson, K, et al.
Published: (2004)

An investigation of the role of mutations in the spliceosome machinery in the myelodysplastic syndromes
by: Lee, J
Published: (2022)

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
by: Fidler, C, et al.
Published: (2004)

Gene expression profiling in the myelodysplastic syndromes.
by: Pellagatti, A, et al.
Published: (2005)

Bi-allelic loss-of-function CACNA1B mutations in progressive epilepsy-dyskinesia
by: Gorman, KM, et al.
Published: (2019)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
by: Boultwood, J, et al.
Published: (2009)

Telomere length in myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (1997)

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
by: Pellagatti, A, et al.
Published: (2017)

Allele frequencies of CSF1 PO, TPOX and TH01 STRs in random Chinese population of Malaysia
by: Swaran, Yuvaneswari D/0 Chandramoulee
Published: (2004)

Response to "treating patients rather than their functional neuroimages" (Br J Anaesth 2018; 121: 969-71)
by: Wanigasekera, V, et al.
Published: (2019)

Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations.
by: Will, B, et al.
Published: (2012)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.
by: Fernandez-Mercado, M, et al.
Published: (2013)

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression
by: Fernandez-Mercado, M, et al.
Published: (2013)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
by: Boultwood, J, et al.
Published: (2010)

A Myelodysplastic Syndrome Associated with a Clonal GATA1 Mutation.
by: Freson, K, et al.
Published: (2008)

SF3B1 mutant myelodysplastic syndrome: Recent advances
by: Pellagatti, A, et al.
Published: (2020)

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR GENE IN MYELODYSPLASTIC SYNDROMES - REPLY
by: Boultwood, J, et al.
Published: (1991)

Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
by: Boultwood, J
Published: (2009)

8 Gene expression profiling in patients with myelodysplastic syndromes, including patients with the del(5q)
by: Boultwood, J
Published: (2009)

Crystal structures of HIV-1 reverse transcriptase mutated at codons 100, 106 and 108 show nevirapine resistance is mediated via perturbation of interactions with Tyr181 or Tyr188
by: Stammers, D, et al.
Published: (2002)

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
by: Fernandez-Mercado, M, et al.
Published: (2013)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 In Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
by: Fernandez-Mercado, M, et al.
Published: (2010)

Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations
by: Choudhary, GS, et al.
Published: (2022)